Modus Operandi

» cancer and genetics & genomics

Most Recent

image: Wanted: Transcriptional Regulators

Wanted: Transcriptional Regulators

By | August 1, 2016

Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.

0 Comments

image: A New Way to ID Targets of RNA-Binding Proteins

A New Way to ID Targets of RNA-Binding Proteins

By | July 1, 2016

The catalytic domain of an RNA-editing enzyme is fused with RNA-binding proteins.

0 Comments

image: Sensors for All

Sensors for All

By | May 1, 2016

A versatile modular strategy for detecting small molecules in eukaryotes

0 Comments

image: Tumor-Shrinking Triple-Helices

Tumor-Shrinking Triple-Helices

By | April 1, 2016

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Gene Editing Without Foreign DNA

Gene Editing Without Foreign DNA

By | February 1, 2016

Scientists perform plant-genome modifications on crops without using plasmids.

0 Comments

image: Bursting Cancer’s Bubble

Bursting Cancer’s Bubble

By | April 1, 2015

Scientists make oxygen-filled microbubbles designed to increase tumor sensitivity to radiation.

3 Comments

image: Exit Strategy

Exit Strategy

By | January 1, 2014

Scientists come up with a better way to watch cells leave blood vessels.

0 Comments

image: BRET Meets FRET

BRET Meets FRET

By | May 1, 2013

Scientists create biocompatible, self-luminescing nanoparticles for in vivo imaging.

0 Comments

image: A Brighter Beacon

A Brighter Beacon

By | April 1, 2012

A novel liquid laser set-up can detect single nucleotide mutations in a cancer gene.

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech